Related Experiment Videos

Systemic group D streptococcal infection in newborn infants

Insights

Group D streptococcal neonatal infections, including sepsis and meningitis, are typically low-grade systemic diseases in infants. Prompt antibiotic treatment with penicillin and aminoglycosides leads to favorable clinical responses in most neonates.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Streptococcal Infections

Background:

  • Group D streptococcus (GDS) can cause serious neonatal infections.
  • Neonatal sepsis and meningitis present significant challenges in pediatric care.

Purpose of the Study:

  • To review cases of group D streptococcal neonatal sepsis and/or meningitis.
  • To analyze clinical presentation, diagnostic findings, and treatment outcomes.

Main Methods:

  • Retrospective review of 13 cases at Cincinnati Children's Hospital (1970-1976).
  • Analysis of patient demographics, symptoms, laboratory results, and treatment regimens.

Main Results:

  • Common symptoms included fever, lethargy, and respiratory distress.
  • Blood and/or cerebrospinal fluid (CSF) cultures confirmed infection in most cases.
  • 12 of 13 infants received penicillin and an aminoglycoside, with 7 showing rapid improvement.

Conclusions:

  • Group D streptococcal infections in neonates often manifest as low-grade systemic disease.
  • Appropriate antibiotic therapy, particularly penicillin and aminoglycosides, is effective and leads to favorable outcomes.

Related Concept Videos